Ovarian Hyperstimulation Syndrome Prevention
Recruiting · NCT06739759 · Interventional (participants receive a specific treatment) · Lead sponsor: Aljazeera Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Antagonist protocol for IVFModified Agonist protocol for IVF with additive treatments as HCQ
What this trial is about
Ovarian hyperstimulation is a very hazardous complication of ICSI
Who can take part
Age range
19 Years to 42 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Women with PCOS coming for ICSI
Exclusion criteria
- Women who donnot have PCOS
Where it is running
2 locations listed.
- Aljazeerah hospital - Giza, Egypt
- Algazeerah - Giza, Egypt